Abstract
Summary
The Asia-Pacific dialysis machines and consumables market is expected to reach USD 4.88 billion by 2031 from USD 3.18 billion in 2023, growing at a CAGR of 5.6% in the forecast period of 2024 to 2031.
Market Segmentation
Asia-Pacific Dialysis Machines and Consumables Market, By Type (Hemodialysis and Peritoneal), Product Type (Hemodialysis and Peritoneal Dialysis), Disease Type (Chronic and Acute), End Use (Hospitals, Dialysis Centers, Home Care Settings, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Philippines, Malaysia, New Zealand, and Rest of Asia-Pacific) – Industry Trends and Forecast to 2031
Overview of Asia-Pacific Dialysis Machines and Consumables Market Dynamics
Driver
• Increasing prevalence of kidney diseases
Restraint
• High cost of treatment in developing countries
Opportunity
• Government initiatives for various renal-related problems
Market Players
Some of the major market players operating in the Asia-Pacific dialysis machines and consumables market are:
• Fresenius SE & Co. KGaA
• Baxter
• NIPRO
• Evoqua Water Technologies LLC
• Medtronic
• B. Braun SE
• Nikkiso Co., Ltd.
• JMS Co. Ltd.
• Jafron Biomedical Co., Ltd.
• Asahi Kasei Medical Co., Ltd.
• Atlantic Biomedical
• dialifegroup
• Advin Health Care
Table of Contents
1 INTRODUCTION 74
1.1 OBJECTIVES OF THE STUDY 74
1.2 MARKET DEFINITION 74
1.3 OVERVIEW OF THE ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET 74
1.4 CURRENCY AND PRICING 76
1.5 LIMITATIONS 76
1.6 MARKETS COVERED 76
2 MARKET SEGMENTATION 79
2.1 MARKETS COVERED 79
2.2 GEOGRAPHICAL SCOPE 80
2.3 YEARS CONSIDERED FOR THE STUDY 81
2.4 DBMR TRIPOD DATA VALIDATION MODEL 82
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 85
2.6 MULTIVARIATE MODELLING 86
2.7 MARKET APPLICATION COVERAGE GRID 87
2.8 PRODUCT LIFELINE CURVE 88
2.9 DBMR MARKET POSITION GRID 89
2.10 VENDOR SHARE ANALYSIS 90
2.11 SECONDARY SOURCES 91
2.12 ASSUMPTIONS 91
3 EXECUTIVE SUMMARY 92
4 PREMIUM INSIGHTS 94
4.1 PESTEL ANALYSIS 95
4.2 PORTER’S FIVE FORCES 96
5 MARKET OVERVIEW 97
5.1 DRIVERS 99
5.1.1 INCREASING PREVALENCE OF KIDNEY DISEASES 99
5.1.2 GROWING DEMAND FOR HOME-BASED DIALYSIS TREATMENTS 100
5.1.3 INCREASING AWARENESS ABOUT KIDNEY DISEASES 101
5.1.4 FAVORABLE REIMBURSEMENT POLICIES FOR DIALYSIS TREATMENT IN DEVELOPED COUNTRIES 101
5.2 RESTRAINTS 102
5.2.1 HIGH COST OF TREATMENT IN DEVELOPING COUNTRIES 102
5.2.2 RISK OF BLOODSTREAM INFECTIONS IN PATIENTS UNDERGOING DIALYSIS TREATMENT 103
5.2.3 AVAILABILITY OF KIDNEY TRANSPLANTATION AS AN ALTERNATIVE TREATMENT 104
5.3 OPPORTUNITIES 105
5.3.1 GOVERNMENT INITIATIVES FOR VARIOUS RENAL-RELATED PROBLEMS 105
5.3.2 STRATEGIC PARTNERSHIPS AMONG THE KEY MARKET PLAYERS 105
5.3.3 GROWING ADOPTION OF TECHNOLOGICALLY ADVANCED PRODUCTS 106
5.4 CHALLENGES 107
5.4.1 SHORTAGE OF SKILLED WORKFORCE FOR CONDUCTING THE DIALYSIS PROCEDURE 107
5.4.2 STRICT REGULATIONS IMPOSED BY THE GOVERNMENT AUTHORITIES 108
6 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY TYPE 110
6.1 OVERVIEW 111
6.2 HEMODIALYSIS 114
6.2.1 SHORT DAILY HEMODIALYSIS 114
6.2.2 CONVENTIONAL HEMODIALYSIS 114
6.2.3 NOCTURNAL HEMODIALYSIS 114
6.3 PERITONEAL 115
6.3.1 AUTOMATED PERITONEAL DIALYSIS 115
6.3.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 115
7 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY PRODUCT TYPE 116
7.1 OVERVIEW 117
7.2 HEMODIALYSIS 120
7.2.1 CONSUMABLES 121
7.2.2 MACHINE 122
7.3 PERITONEAL DIALYSIS 123
8 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY DISEASE TYPE 125
8.1 OVERVIEW 126
8.2 CHRONIC 129
8.2.1 HEMODIALYSIS 129
- 8.2.1.1 SHORT DAILY HEMODIALYSIS 130
- 8.2.1.2 CONVENTIONAL HEMODIALYSIS 130
- 8.2.1.3 NOCTURNAL HEMODIALYSIS 130
8.2.2 PERITONEAL 130
- 8.2.2.1 AUTOMATED PERITONEAL DIALYSIS 130
- 8.2.2.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 130
8.3 ACUTE 131
8.3.1 HEMODIALYSIS 131
- 8.3.1.1 SHORT DAILY HEMODIALYSIS 132
- 8.3.1.2 CONVENTIONAL HEMODIALYSIS 132
- 8.3.1.3 NOCTURNAL HEMODIALYSIS 132
8.3.2 PERITONEAL 132
- 8.3.2.1 AUTOMATED PERITONEAL DIALYSIS 132
- 8.3.2.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 132
9 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY END USE 133
9.1 OVERVIEW 134
9.2 HOSPITALS 137
9.2.1 CHRONIC 137
9.2.2 ACUTE 137
9.3 DIALYSIS CENTERS 138
9.3.1 CHRONIC 138
9.3.2 ACUTE 138
9.4 HOME CARE SETTINGS 139
9.4.1 CHRONIC 139
9.4.2 ACUTE 139
9.5 OTHERS 140
10 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY DISTRIBUTION CHANNEL 141
10.1 OVERVIEW 142
10.2 DIRECT TENDERS 145
10.3 RETAIL SALES 145
10.4 OTHERS 146
11 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY REGION 147
11.4 ASIA-PACIFIC 309
11.4.1 JAPAN 320
11.4.2 SOUTH KOREA 330
11.4.3 CHINA 341
11.4.4 INDIA 352
11.4.5 MALAYSIA 362
11.4.6 THAILAND 373
11.4.7 AUSTRALIA 384
11.4.8 SINGAPORE 395
11.4.9 INDONESIA 405
11.4.10 PHILIPPINES 415
11.4.11 REST OF ASIA-PACIFIC 426
12 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET: COMPANY LANDSCAPE 527
12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 527
13 SWOT ANALYSIS 531
14 COMPANY PROFILE 532
14.1 FRESENIUS SE & CO. KGAA 532
14.1.1 COMPANY SNAPSHOT 532
14.1.2 REVENUE ANALYSIS 532
14.1.3 COMPANY SHARE ANALYSIS 533
14.1.4 PRODUCT PORTFOLIO 533
14.1.5 RECENT DEVELOPMENT 534
14.2 BAXTER 535
14.2.1 COMPANY SNAPSHOT 535
14.2.2 REVENUE ANALYSIS 535
14.2.3 COMPANY SHARE ANALYSIS 536
14.2.4 PRODUCT PORTFOLIO 536
14.2.5 RECENT DEVELOPMENT 536
14.3 NIPRO 537
14.3.1 COMPANY SNAPSHOT 537
14.3.2 REVENUE ANALYSIS 537
14.3.3 COMPANY SHARE ANALYSIS 538
14.3.4 PRODUCT PORTFOLIO 538
14.3.5 RECENT DEVELOPMENT 538
14.4 EVOQUA WATER TECHNOLOGIES LLC 539
14.4.1 COMPANY SNAPSHOT 539
14.4.2 REVENUE ANALYSIS 539
14.4.3 COMPANY SHARE ANALYSIS 540
14.4.4 PRODUCT PORTFOLIO 540
14.4.5 RECENT DEVELOPMENT 541
14.5 MEDTRONIC 542
14.5.1 COMPANY SNAPSHOT 542
14.5.2 REVENUE ANALYSIS 542
14.5.3 COMPANY SHARE ANALYSIS 543
14.5.4 PRODUCT PORTFOLIO 543
14.5.5 RECENT DEVELOPMENT 544
14.6 ADVIN HEALTH CARE 545
14.6.1 COMPANY SNAPSHOT 545
14.6.2 PRODUCT PORTFOLIO 545
14.6.3 RECENT DEVELOPMENT 545
14.7 ASAHI KASEI MEDICAL CO., LTD 546
14.7.1 COMPANY SNAPSHOT 546
14.7.2 REVENUE ANALYSIS 546
14.7.3 PRODUCT PORTFOLIO 547
14.7.4 RECENT DEVELOPMENT 548
14.8 ATLANTIC BIOMEDICAL 549
14.8.1 COMPANY SNAPSHOT 549
14.8.2 PRODUCT PORTFOLIO 549
14.8.3 RECENT DEVELOPMENT 550
14.9 B. BRAUN SE 551
14.9.1 COMPANY SNAPSHOT 551
14.9.2 PRODUCT PORTFOLIO 551
14.9.3 RECENT DEVELOPMENT 551
14.10 DIALIFEGROUP 552
14.10.1 COMPANY SNAPSHOT 552
14.10.2 PRODUCT PORTFOLIO 552
14.10.3 RECENT DEVELOPMENT 553
14.11 JAFRON BIOMEDICAL CO., LTD 554
14.11.1 COMPANY SNAPSHOT 554
14.11.2 PRODUCT PORTFOLIO 554
14.11.3 RECENT DEVELOPMENT 554
14.12 JMS CO. LTD 555
14.12.1 COMPANY SNAPSHOT 555
14.12.2 REVENUE ANALYSIS 555
14.12.3 PRODUCT PORTFOLIO 556
14.12.4 RECENT DEVELOPMENT 556
14.13 NIKKISO CO., LTD 557
14.13.1 COMPANY SNAPSHOT 557
14.13.2 REVENUE ANALYSIS 557
14.13.3 PRODUCT PORTFOLIO 558
14.13.4 RECENT DEVELOPMENT 559
15 QUESTIONNAIRE 560
16 RELATED REPORTS 563